Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,727,477
+$19,727,477 QoQ
Shares Held
582,275
Ownership
0.050%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#103
of 673 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2025CallValue
$4,747,041
CallShares
152,100
PutValue
$5,205,828
PutShares
166,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $64,073,206 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (30.8% of the industry book) .
All Filings in TEVA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,727,477 | 582,275 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $4,747,041 | 152,100 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $5,205,828 | 166,800 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $4,316,740 | 213,700 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $3,941,020 | 195,100 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $10,815,228 | 645,300 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $9,777,784 | 583,400 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $9,092,892 | 591,600 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $9,918,261 | 645,300 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $981,128 | 63,834 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,428,566 | 64,817 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||